Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency
Despina Moshous(Hôpital Necker-Enfants Malades), Jean‐Pierre de Villartay(Université Paris Cité), Régina de Chasseval(Hôpital Necker-Enfants Malades), Alain Fischer(Inserm), İlhan Tezcan(Hacettepe University Hospital), Özden Sanal(Hacettepe University), Isabelle Callebaut(Centre National de la Recherche Scientifique), Yves Bertrand(Hôpital Debrousse), Noël Philippe(Hôpital Debrousse), Marina Cavazzana(Université Rennes 2), Françoise Le Deist(Centre National de la Recherche Scientifique), Barbara Corneo(Hôpital Necker-Enfants Malades)
Cited by 901
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k